Sosei Collaborates With GSK On Immune Disorders Of Digestive System; Eligible To Receive Up $481 Mln
(RTTNews) - Japan's Sosei Group Corp said that it has reached a global collaboration and license agreement with GlaxoSmithKline Plc (GSK.L, GSK) targeting immune disorders of the digestive system in a ...
GlaxoSmithKline (GSK) plans to settle "the vast majority" of several hundred lawsuits that allege consumers suffered zinc poisoning and neurological disabilities after using GSK Super Poligrip denture ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today a multi-year collaboration with GSK on the development of a next-generation equipment design, building upon Pfizer’s existing portable ...
GSK is paying $70 million to plug into Tempus’ AI-enabled patient data platform with the aim of improving its clinical trial design, speeding up enrollment and identifying new drug targets. Tempus’ ...
Earlier this year, we projected that 2021 would be the year of quantum computing for drug discovery, positing the idea that this is one of only a few areas where there is big ROI to offset the work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results